Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06071559
Other study ID # 2014/1793-31/1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2015
Est. completion date June 1, 2022

Study information

Verified date October 2023
Source Ersta Diakoni
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this prospective cohort study is to examine circulating biomarkers before and after weight loss in patients with obesity, with or without concomitant diabetes, undergoing bariatric surgery. The main questions that are being addressed are: - Do biomarkers of hemostasis, including coagulation, fibrinolysis, and platelet function improve following surgery and if so, is that improvement more pronounced in patients with diabetes? - Do biomarkers of endothelial function and other aspects of vascular function improve following surgery and if so, is that improvement more pronounced in patients with diabetes? - Do biomarkers of inflammation, including markers of adipocyte function, improve following surgery and if so, is that improvement more pronounced in patients with diabetes? - The possible role of circulating extracellular vesicles reflecting biological functions above will also be investigated (optional) Participants will be asked to attend in total five study visits before and after surgery including a final visit at two years post-surgery. Comparisons will be performed within- as well as between groups.


Description:

In this single centre, prospective, parallel group, cohort study, patients meeting the eligibility criteria are recruited at the department of surgery at Ersta hospital, Stockholm, Sweden. Patients with obesity and type 2 diabetes (T2D) are matched for age and sex with the group of patients with obesity without T2D. During the study the participants attend five study visits: at baseline, at the morning of surgery (after two weeks of low calory diet), 6 weeks, 1 year and 2 years after surgery. At each study visit a nurse records blood pressure, weight, height, and waist/hip circumferences. In addition, the nurse recalls the medical history and any medication use including contraceptive hormones and analgesics. Fat mass is determined using bioelectric impedance. Venous blood samples are collected with the patients in the supine position after overnight fasting and at least 20 minutes of rest. For later analyses, 25 mL of blood is collected in citrate tubes and centrifuged for 20 min at 2000 x g in room temperature. Plasma aliquots are subsequently stored at minus 80 degrees Celsius. Blood test regarding values at baseline (not the primary outcome variables) will be analysed at the local hospital laboratory. Examples of those basic variables are concentrations of glucose, insulin, blood cell counts and lipids.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date June 1, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion criteria: - Age 18-70 years old - Planned for Roux-en-y gastric bypass surgery - Obesity fulfilling criteria for bariatric surgery (according to the European Association for the Study of Obesity guidelines, ref. Yumuk et al. European Guidelines for Obesity Management in Adults. Obes Facts 2015;8:402-42.) Exclusion criteria: - Ongoing treatment with anticoagulant medication - Ongoing treatment with antiplatelet medication other than acetylsalicylic acid - Type 1 diabetes

Study Design


Intervention

Procedure:
Laparoscopic Roux-en-y gastric bypass
Obesity surgery

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Ersta Diakoni Karolinska Institutet

Outcome

Type Measure Description Time frame Safety issue
Primary Blood tests for endothelial function comparing two years after surgery with baseline (below referred to as "changes in"). Outcome measure:
Change in Hyaluronan (ng/ml)
Change in Syndacan-1 (ng/ml)
Change in E-selectin (ng/ml)
Change in Thrombomodulin (pg/ml)
Change in von Willebrand factor (%)
before surgery - 2 years after surgery
Primary Blood tests for fibrinolysis comparing two years after surgery with baseline (below referred to as "changes in"). Outcome measure:
Change in PAI-1 activity (IU/ml)
Change in Fibrinogen (pg/ml)
Change in tPA activity (IU/ml)
Change in PAP complex (ng/ml)
Change in turbidimetric values - LagC (s)
Change in turbidimetric values - LagL (s)
Change in turbidimetric values - MaxAbsC (au)
Change in turbidimetric values - MaxAbsL (au
Change in turbidimetric values - Lys50MA (s)
Change in turbidimetric values - CRC (au/s)
Change in turbidimetric values - CRL (au/s)
before surgery - 2 years after surgery
Primary Blood tests for inflammation comparing two years after surgery with baseline (below referred to as "changes in"). Outcome measure:
Change in high sensitivity CRP (microg/ml)
Change in soluble IL6 receptor (ng/mL)
Change in IL6 (pg/mL)
Change in soluble gp130 (ng/mL)
Change in TNFalfa (pg/ml)
before surgery - 2 years after surgery
Primary Blood tests for extracellular vesicles comparing two years after surgery with baseline (below referred to as "changes in"). Exploratory analyses of extracellular vesicles (EV) in plasma using flow cytometry. EV exposing antigens of cell specific origin and/or biologically active molecules will be assessed. Outcome measure: Change in number of EVs (number of EV/micoL) before surgery - 2 years after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Terminated NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A